Stay updated on BCMA CAR T Cells ± Lenalidomide in Myeloma Clinical Trial

Sign up to get notified when there's something new on the BCMA CAR T Cells ± Lenalidomide in Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the BCMA CAR T Cells ± Lenalidomide in Myeloma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-05-01T06:16:36.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The web page has been updated to include specific details about a phase I clinical trial for Multiple Myeloma, including the study's design and collaborators, while removing previous descriptions of the trial's purpose and inclusion/exclusion criteria.
    Difference
    36%
    Check dated 2025-04-16T20:26:17.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4 and has removed several previous dates while adding new ones for April 2025.
    Difference
    0.8%
    Check dated 2025-04-09T13:52:50.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    The webpage has updated its date references, removing older dates and adding new ones for 2025 and 2026.
    Difference
    0.7%
    Check dated 2025-03-11T07:57:47.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    2%
    Check dated 2025-02-24T23:09:28.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    The page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    2%
    Check dated 2025-02-10T16:49:02.000Z thumbnail image

Stay in the know with updates to BCMA CAR T Cells ± Lenalidomide in Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the BCMA CAR T Cells ± Lenalidomide in Myeloma Clinical Trial page.